News
News
- Actelion's Annual General Meeting of Shareholders 2017
04/05/2017 / 12:35 - GlobeNewswire - Johnson & Johnson publishes interim result for Actelion tender offer and declares the tender offer successful
03/31/2017 / 07:00 - GlobeNewswire - Actelion issues invitation to 2017 Annual General Meeting of Shareholders
03/15/2017 / 07:00 - GlobeNewswire - Actelion is granted marketing authorization by the European Commission for Ledaga (chlormethine gel) for the treatment of MF-CTCL
03/07/2017 / 07:00 - GlobeNewswire - Actelion obtains "Epoprostenol ACT" label extension for pediatric PAH patients in Japan
03/02/2017 / 07:00 - GlobeNewswire - Johnson & Johnson publishes prospectus for Actelion tender offer
02/16/2017 / 07:00 - GlobeNewswire - Actelion announces excellent financial results for 2016
02/14/2017 / 07:00 - GlobeNewswire - Actelion concludes second line share repurchase program
02/10/2017 / 17:35 - GlobeNewswire - Europe closes lower on Trump's remarks
01/31/2017 / 17:32 - TeleTrader - CORRECTION: JOHNSON & JOHNSON TO ACQUIRE ACTELION FOR $30 BILLION WITH SPIN-OUT OF NEW R&D COMPANY
01/26/2017 / 09:08 - GlobeNewswire
Real-time